SCHEMBL5369537

SCHEMBL5369537

CC(=O)CC/C=C(\C)CC/C=C(\C)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.51
BACE1 P56817 2/20 0.49
KDM4E B2RXH2 1/20 0.48
ATM Q13315 1/20 0.48
FNTA P49354 5/20 0.47
FNTB P49356 5/20 0.47
KMT2A Q03164 3/20 0.46
KDM1A O60341 1/20 0.46
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
TRPA1 O75762 1/20 0.43
POLB P06746 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
UGT1A1 P22309 1/20 0.42
SQLE Q14534 1/20 0.41
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10577114 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL10571838 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL27626845 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL10574296 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL5369541 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL10574231 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL10571831 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL10574272 1.00 PPARG (0.51) PPARGBACE1KDM4EATMFNTA
SCHEMBL2918368 0.91 KDM4E (0.45) PPARGBACE1KDM4EATMFNTA
SCHEMBL2918372 0.91 KDM4E (0.45) PPARGBACE1KDM4EATMFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100432041-C Method for producing oxygen-containing compound SUMITOMO CHEMICAL CO (JP) 2008-11-12 CN disclosed
US-7276622-B2 Method for producing oxygen-containing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-02 US disclosed
US-20060173221-A1 Method for producing oxygen-containing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-03 US disclosed
CN-1761641-A Method for producing oxygen-containing compound SUMITOMO CHEMICAL CO (JP) 2006-04-19 CN disclosed
EP-1609777-A1 METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND Sumitomo Chemical Company, Limited (JP) 2005-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173221-A1 Method for producing oxygen-containing compound GPX4, DUOX2, SCO2 PPARG 1734/4885BACE1 3217/4885KDM4E 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.